USPTO serial 79045844
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
WILLIAM S FROMMER
WILLIAM S FROMMER FROMMER LAWRENCE & HAUG LLP745 5TH AVENEW YORK, NY 10151UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in the treatment of oncological diseases; Pharmaceutical preparations for use in treatment of neurological diseases; Pharmaceutical preparations for use in treatment of endocrine disorders; Pharmaceutical preparations for use in treatment of urological diseases; Pharmaceutical preparations for use in treatment of hormonal disorders; Pharmaceutical preparations for the treatment of gastrointestinal bleeding disorders; and Pharmaceutical preparations for use in treatment of blood disorders, blood plasma | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 27, 2018 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Apr 27, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 7, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| May 3, 2016 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| May 3, 2016 | INPC | INVALIDATION PROCESSED | — |
| Mar 24, 2016 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 24, 2015 | C71T | CANCELLED SECTION 71 | — |
| Apr 14, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 12, 2009 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 3, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 3, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 23, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 22, 2009 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Dec 23, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 7, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 17, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 2, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 2, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 7, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 7, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2008 | ALIE | ASSIGNED TO LIE | — |
| Aug 1, 2008 | PAPER RECEIVED | — | |
| Feb 15, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 31, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 31, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 31, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 30, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 23, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 30, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Nov 29, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |